New pill plus injection shows promise for Crohn's – but trial halted early
NCT ID NCT04978493
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether adding an experimental oral drug (BI 706321) to the standard treatment ustekinumab helps people with moderate to severe Crohn's disease. About 49 adults took either the combination or a placebo plus ustekinumab for 12 weeks, followed by ustekinumab alone. The trial was terminated early, so results are limited, but researchers looked at changes in bowel inflammation and overall health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BI 706321 (an experimental oral drug) plus ustekinumab (an approved injectable drug)
- What this could lead to
- If it works, this combination could offer a new treatment option for people with moderate to severe Crohn's disease.
- What could go wrong
- This is an early (Phase 2) trial that was terminated, so results may be limited. The added benefit of BI 706321 over ustekinumab alone is not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AZ Maria Middelares
Ghent, 9000, Belgium
-
AZ Sint-Lucas - Campus Sint Lucas
Ghent, 9000, Belgium
-
Aalborg Sygehus Syd
Aalborg, 9100, Denmark
-
Advanced Research Institute, Inc.
Orlando, Florida, 32825, United States
-
Az. Ospedaliera Universitaria Polic.Tor Vergata
Roma, 00133, Italy
-
BVL Clinical Research
Liberty, Missouri, 64068, United States
-
Brussels - UNIV St-Pierre
Brussels, 1000, Belgium
-
Bugat Pal Hospital, Gyongyos
Gyöngyös, 3200, Hungary
-
CEIC Corporacio Sanitaria Parc Taulí
Sabadell, 08208, Spain
-
California Medical Research Associates Inc.
Northridge, California, 91324, United States
-
Carolina Digestive Diseases
Greenville, North Carolina, 27834, United States
-
Centre Hospitalier Universitaire de Liège
Liège, 4000, Belgium
-
Centrum Opieki Zdrowotnej Orkan-Med Stec-Michalska sp. j.
Ksawerów, 95-054, Poland
-
Clinexpert Kft.
Budapest, 1033, Hungary
-
Fondazione IRCCS Policlinico S. Matteo
Pavia, 27100, Italy
-
GI Alliance
Southlake, Texas, 76092, United States
-
Gastroenterology Associates of Western Michigan
Wyoming, Michigan, 49519, United States
-
Healthcare Center Gastromed - SCANMED GROUP
Lublin, 20-582, Poland
-
Hepato-Gastroenterologie HK, s.r.o.
Hradec Králové, 50002, Czechia
-
Hospital La Princesa
Madrid, 28006, Spain
-
Hospital Politècnic La Fe
Valencia, 46026, Spain
-
Hospital Virgen Macarena
Seville, 41071, Spain
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
I.H.S Health, LLC
Kissimmee, Florida, 34741, United States
-
IRCCS Fondazione Ospedale Maggiore
Milan, 20122, Italy
-
IRCCS Policlinico San Donato
San Donato Milanese (MI), 20097, Italy
-
IRCCS San Raffaele
Milan, 20132, Italy
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Indywidualna Specjalistyczna Praktyka Lekarska Maciej Zymla
Knurów, 44-190, Poland
-
NZOZ Medical Center KERmed
Bydgoszcz, 85231, Poland
-
National Medical Institute MSWiA
Warsaw, 02-507, Poland
-
Nature Coast Clinical Research
Inverness, Florida, 34452, United States
-
Osp.Sacro Cuore-Don Calabria
Negrar (VR), 37024, Italy
-
Policlinico Universitario Mater Domini, Universita di Catanzaro
Catanzaro, 88100, Italy
-
Radboud Universitair Medisch Centrum
Nijmegen, 6525 GA, Netherlands
-
Royal Liverpool University Hospital
Liverpool, L7 8XP, United Kingdom
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Southern Star Research Institute, LLC
San Antonio, Texas, 78229, United States
-
St Elisabeth Ziekenhuis
Tilburg, 5022 GC, Netherlands
-
Sweet Hope Research Specialty Inc
Hialeah, Florida, 33016, United States
-
Twoja Przychodnia-Szczecinskie Centrum Medyczne
Szczecin, 71-434, Poland
-
UNIV Ambroise Paré
Mons, 7000, Belgium
-
UZ Leuven
Leuven, 3000, Belgium
-
University Hospital Ostrava
Ostrava, 708 52, Czechia
-
University of Debrecen Clinical Centre
Debrecen, 4032, Hungary
-
University of Utah Health Sciences Center
Salt Lake City, Utah, 84132, United States
-
University of Washington
Seattle, Washington, 98195, United States
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
-
payee-Hospital Universitario Reina Sofia. Cordoba
Córdoba, 14004, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a patient registry unlock the secrets of IBD?
- Can we predict how kids with IBD will respond to treatment?
- Can switching IBD meds heal the gut when symptoms are quiet?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?
- Can a Real-World study reveal the staying power of guselkumab?